PEDEvidence

SOURCE-LINKED STUDY SUMMARY

An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity.

The Journal of pharmacology and experimental therapeutics ·

Animal

Abstract summarized · Quality not appraised
Studied
SLU-PP-915, an orally active compound that activates energy-regulating ERR receptors, was tested for exercise-related effects.
Who / model
Preclinical experiments were reported. The abstract does not clearly specify the animals or sample size for the SLU-PP-915 experiments.
Studied dose & schedule
Dose and schedule have not yet been extracted for this summary.
Found
The compound increased exercise distance and duration. Activity was retained with oral delivery after accounting for exposure.
Limits
The abstract presents SLU-PP-915 as a research tool for further study; it does not establish clinical benefits in people.

Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary

Research findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.

Original publication ↗ · DOI: 10.1016/j.jpet.2025.103787

Explore related compounds

How summaries and evidence labels are prepared

← All study summaries